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ABSTRACT 
 
Kristen N. Evans.  PREDICTING COMPLIANCE IN VOICE THERAPY USING THE VOICE 
HANDICAP INDEX.  (Under the direction of Kathleen T. Cox, Ph.D.)  Department of 
Communication Sciences and Disorders, May 2010. 
 
 Research indicates that it is not uncommon for patients to cancel or postpone scheduled 
appointments for speech therapy designed to improve the voice, i.e., voice therapy.  The purpose 
of this study is to determine if patient perceptions of their voice and vocal problems will predict 
which patients exhibit noncompliance with a voice therapy program.  The present study also 
analyzed the effects of demographic variables (i.e. age, gender, occupation, etc.) on patient 
compliance with voice therapy. 
 Twenty-five patient participants were included in this study.  Before undergoing voice 
therapy, these participants were asked to complete the Voice Handicap Index (VHI) in order to 
obtain a subjective measure of how their vocal “problems” have affected their everyday lives: 
physically, emotionally, and functionally.  The VHI is a standardized patient attitude rating scale 
that has been shown to document similar issues with patient compliance. Prior to this study, 
however, variables including occupation, type of insurance coverage, and driving distance from 
the clinic were not included in those analyses.  The individual questions of the VHI were also 
analyzed in comparison to adherence to therapy recommendations. 
Descriptive analyses of the data revealed that the VHI scores and responses to individual 
VHI questions provided no practical significance in predicting patient compliance or 
noncompliance to voice therapy.  In addition, analyses of demographic variables did not offer 
information that had practical significance regarding patient compliance or noncompliance to 
therapy. 
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CHAPTER I 
REVIEW OF LITERATURE 
 Speech-language therapy requires active patient participation which often involves 
practicing target objectives within therapy sessions and at home.  Effectiveness of therapy is 
affected by patient compliance (Hopwood, Creech, Clark, Meagher and More, 2007) in that a 
patient may not make the desired progress without actively making lifestyle changes and 
practicing exercises as suggested by a speech-language pathologist (SLP).  Patient 
noncompliance with therapy also impacts “cost-effectiveness” of healthcare (Hopwood et al., 
2007; Portone, Johns, and Harper, 2006).  Like with many other forms of therapy, patients often 
demonstrate noncompliance in voice therapy. The noncompliant behaviors may be contributed to 
factors such as resistance to change and may include a lack of follow-through outside the therapy 
session (Portone et al., 2008). 
Voice therapy is a term that includes a vast array of treatments designed to improve the 
voice. Voice therapy may contain instruction in vocal hygiene education, phonatory retraining 
and medical management.  Typically, an SLP administers voice therapy tasks including voice 
exercises, education, and counseling related to the voice disorder.  An ENT or other physician 
oversees medical management which could include the behavioral treatment provided by the 
SLP, surgical treatments, and medical treatments (i.e., medications).     
From the view of an SLP, voice therapy is a form of behavioral intervention that 
facilitates a patient changing behaviors that cause or contribute to a voice disorder.  This may 
include attempting to improve phonatory functioning despite the etiology of the disorder (i.e., not 
all voice disorders are caused by inappropriate vocal behavior but can be improved with 
behavioral voice therapy).  Positive therapeutic outcomes for patients have been acknowledged 
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in many studies regarding voice therapy (Behrman et al., 2008; Blood, 1994; Gordon, Pearson, 
Paton, & Montgomery, 1997; Gullivan-Murphy, Drinnan, O’Dwyer, Ridha, & Carding, 2006; 
Lancer, Syder, Jones, & Le Boutillier, 1988; MacKenzie, Millar, Wilson, Sellars, & Deary, 2001; 
McCrory, 2001; Murry & Woodson, 1992; Sellars, Carding, Deary, MacKenzie, & Wilson, 
2002; S. Smith & Thyme, 1976; Speyer, Weineke, Hosseini, Kempen, Kersing, & Dejonckere, 
2002; Verdolini-Marston, Burke, Lessac, Glaze, & Caldwell, 1995; Cooper, 1973; Boone, 1971; 
Brodnitz, 1967).  Similar to other healthcare practices, voice therapy is dependent upon active 
patient participation (van Leer, Hapner, and Connor, 2008).  Patient adherence has been shown 
to be vitally important to outcomes of voice therapy (Behrman, Rutledge, Hembree and 
Sheridan, 2008).  Boone (1974) first attempted to determine the significance of patient adherence 
to voice therapy with his development of dismissal criteria for termination of therapy with a 
patient.  Boone’s criteria were created as an attempt to measure the success of voice therapy in 
hyperfunctional voice disorders.  These dismissal criteria included: (1) improvement of the 
organic cause of the voice problem, (2) improvement of the patient’s voice according to a panel 
of judges, (3) the patient’s self-perception of voice improvement, (4) the patient’s perception of 
no improvement or reduction in vocal performance, or (5) the patient ending the therapy without 
the SLP’s permission.  Boone further reported that these criteria may aid the clinician in his or 
her approach to therapy if he or she focuses on helping the patient attain one or all of the first 
three criteria and preventing the occurrence of the last two criteria.  However, his ideas were not 
readily accepted because they did not take into consideration that a patient may need to be 
dismissed for reasons other than noncompliance, having a better feeling of his or her voice, or 
successfully completing therapy objectives (Henrikson, 1975).  Henrikson (1975) argued that 
patients may experience life changes, such as moving or illness that affect their ability to 
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complete voice therapy. 
The terms ‘adherence’ and ‘compliance’ are sometimes used interchangeably.  However, 
the term ‘adherence’ has been favored by some researchers (Behrman, 2006, p. 216; Lutfey and 
Wishner,1999; Miller and Rollnick, 2002) over ‘compliance’ because of its emphasis on a 
patient’s personal decision to follow through with health-related advice and because it takes into 
account the multitude of factors that affect patient behavior.  Shields, Brawley and Lindover 
(2005) also considered the term ‘adherence’ to promote active participation of the individual in 
making decisions regarding his or her own behavior.   
Different views of patient compliance have been advocated over the years.  In the 1970s, the 
term ‘compliance’ was promoted to take the place of ‘recalcitrant’ in reference to patients 
because it was deemed “less judgmental” than the latter (Behrman, 2006, p. 216).  At this time, 
patient compliance was defined as how much a person’s behavior correlated with the medical 
advice of a clinician (Behrman, 2006; Haynes et al., 1979) but some believed that compliance 
was not an appropriate term because of its exclusion of a patient’s personal choice and capacity 
to change his or her lifestyle.  Hapner et al. (2007) considered patient compliance to correlate 
with voice therapy completion.  Their operational definition of voice therapy completion 
included three possible outcomes: if the patient had accomplished his or her therapeutic goals, if 
he or she was satisfied with the results of his or her voice, and if the clinician determined that no 
more progress would be made in therapy (thus, the patient was referred elsewhere).  In order for 
a patient to be considered compliant to voice therapy, he or she must adhere to the 
recommendations made by an SLP and a laryngologist in addition to attending therapy sessions.
 Considering the definition of compliance as advocated by Hapner et al. (2007), 
noncompliance refers to lack of both attendance and adherence to therapeutic recommendations. 
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In a study of compliance in HIV-positive patients, “failure to return,” or noncompliance, was 
defined as individuals who did not return for scheduled medical visits for at least 12 consecutive 
months.  This included deceased patients (Arici, Ripamonti, Maggiolo, Rizzi, Finazzi et al., 
2002, p. 52-53).  Nonadherence refers to a patient’s unwillingness to follow through with 
recommendations for treatment.   Sometimes, patients may attend scheduled medical sessions but 
may consistently fail to adhere to the advice given by a clinician; this is an example of patient 
nonadherence.  Hapner, Johns and Portone-Maira (2007) determined that a patient had dropped 
out of voice therapy when the final therapy note indicated recommendations for further treatment 
and no additional treatment was recorded or if the patient was dismissed due to failure to follow 
through with treatment recommendations.   
Patient perception of their own disorder may contribute to compliance and adherence, or 
lack thereof.  Voice problems are not negligible nor are they “cosmetic” (Verdolini and Ramig, 
2001, p. 37).  However, many individuals who are diagnosed with voice disorders do not make 
the effort to attend voice therapy in order to alleviate the problem.  Evidence exists that suggests 
patient adherence to voice therapy has a more significant impact on therapeutic outcomes than 
the selection of treatment approaches (Hapner et al., 2007).  Despite the role that patient 
adherence to voice therapy plays in therapeutic outcomes, Portone et al. (2006) found in a study 
of patient adherence to voice therapy that many of the patients who were referred for voice 
therapy by their otolaryngologist do not follow through with the referral.  In this study, 38% of 
patients did not comply with a laryngologist’s referral to return for a voice evaluation and 47% 
who attended a voice evaluation did not attend therapy.   
Risk Factors for Voice Disorders: Indicators of Patient Nonadherence 
 
 Hapner et al. (2007) presented their first study on attempting to determine variables that 
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may contribute to patient dropout from voice therapy.  In this study, factors including gender, 
age, race/ethnicity, diagnosis, total Voice Handicap Index (VHI) score, and results of the 
Consensus Auditory Perceptual Evaluation of Voice (CAPE-V) were assessed to determine their 
predictor value for patients’ completion or withdrawal from voice therapy.  Although Hapner et 
al. (2007) found a 65% voice therapy dropout rate altogether, none of the factors they studied for 
predictor value were strongly associated with dropout and, therefore, were not predictive of 
dropout.  Suggestions for future research have involved assessing other possible predictor 
variables such as occupation, insurance coverage, and distance between a patient’s home and a 
voice clinic (Hapner et al., 2007; Portone et al., 2008).   
Few studies are available regarding the occupational impact of voice disorders 
(Herrington-Hall, Lee, Stemple, Niemi, Miller, and McHone, 1988; Roy, Merrill, Gray, and 
Smith, 2005; Roy, Merrill, Thibeault, Gray, and Smith, 2004).  Results of the few studies that 
have been performed have not been consistent with one another.  According to Roy et al. (2005), 
estimates of voice disorders have been variable (15-65%) in the general population.  This wide 
range may be related to inconsistent sampling procedures.  Variable research outcomes may also 
be due to the fact that a single definition for voice problems has not been agreed upon (Verdolini 
and Ramig, 2001). 
 Although not many studies relating to occupational risk factors for voice disorders are 
available, the existing literature suggests that some occupations are more associated with the 
development of voice disorders than others, particularly those occupations that require more 
vocal use (Roy et al., 2005).  In the United States, 25% or more of working individuals depend 
upon their voice as a vital part of their job (Verdolini and Ramig, 2001).  There is a high 
incidence of voice problems among teachers (Roy et al., 2004).  A review of the literature by 
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Verdolini and Ramig (2001) indicated that ‘teacher’ constantly appears as the occupation of 
those individuals most likely to seek an ENT evaluation for a voice problem.  Other frequently 
occurring occupations presenting to a voice clinic include: singers, counselors, social workers, 
lawyers, clergy, and keyboard operators.  Approximately 40% of teachers in the United States 
suffer from hoarseness and about the same number indicate that teaching has negative 
consequences on the voice (Verdolini and Ramig, 2001; Smith et al., 1997).   Roy et al (2004) 
discovered significant differences in the vocal health of teachers versus non-teachers; teachers 
were more likely to have experienced multiple voice symptoms and signs including hoarseness, 
discomfort and increased effort using voice; time and again, teachers ascribed these vocal 
symptoms to their occupation.  Also, many indicated that these problems were affecting their 
work, causing them to have missed more days of work due to these symptoms.  Many had 
considered changing jobs because of these problems (Roy et al, 2004).  Although occupation 
often motivates a patient to seek medical assistance for voice problems, this risk factor for voice 
disorders has not been studied in terms of its effects on determining patient compliance with 
voice therapy. 
 Age may also be a risk factor for voice problems.  Voice disorders commonly affect the 
older population. Using the Quality of Life questionnaire, Verdolini and Ramig (2001) found 
that elderly participants were “disproportionately affected” by voice disorders as compared to 
other participants in different age categories.  This discrepancy may have been due to the current 
increase in average life expectancy, better documentation, and health insurance coverage 
(Herrington-Hall et al., 1988).  A strong correlation between age and completion of voice 
therapy has not been found (Hapner et al., 2007; Portone et al., 2008).  However, Portone et al. 
(2008) found in their study that the age group most likely to attend the first voice therapy session 
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was the 21-40 year old age group, and the least likely to attend were the 40-64 year olds. 
 Gender may play a role in an individual’s development of a voice disorder.  Voice 
pathologies in general appear more often in females than in males (Herrington-Hall et al., 1988).  
Psychogenic voice problems are an example of a voice disorder that is more likely to occur in 
females (Aronson, 1980; Cooper, 1973; Herrington-Hall et al., 1988).  Some disorders such as 
cancer, leukoplakia, and hyperkeratosis have been shown to emerge more in males than in 
females.  This information regarding gender may be partially due to the fact that women seem to 
be more concerned with health and more likely to seek medical attention than men (Cleary, 
Mechanic & Greenley, 1977; Hibbard & Pope, 1986; Nathanson, 1977; Herrington-Hall et al., 
1988).  Anatomical and physiological differences may also cause females more than males to 
seek medical assistance for voice disorders (Hapner et al., 2007). Gender has not been found to 
be a predictor of therapy completion or dropout (Hapner et al, 2007; Portone et al., 2008). 
 Noncompliance with voice therapy may be due to other issues such as financial barriers, 
change in patient perception of a problem, and inconvenience.  According to Portone et al. 
(2006), the major reasons reported by patients in regards to their noncompliance or nonadherence 
to the recommendations for voice therapy included denial of insurance coverage, resolution of 
the problem, and distance from the clinic.  Lack of insurance coverage was the chief reason that 
was reported.  A patient’s inability to drive or lack of transportation also affects his or her 
follow-through with therapy (Hapner et al., 2007; Mashima, Birkmire-Peters, Syms, Holtel, 
Burgess and Peters, 2003).  Patients have also reported that a lack of confidence in the treatment 
was a reason for self-termination of therapy (Hapner et al. 2007).  Hapner et al. (2007) coded 
patients according to their diagnosis of either hypofunctional voice disorder or hyperfunctional 
voice disorder, but they found no significant difference between these diagnostic categories for 
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the completion or dropout of voice therapy.   
Voice Handicap Index 
 
The Voice Handicap Index (VHI) is a perceptual assessment tool used to obtain a 
patient’s perception of the effects of his or her voice disorder on three aspects of his or her 
personal life: physical, emotional and functional.  The physical component addresses a patient’s 
perception of discomfort and the voice, the emotional sub-scale is used to analyze the patient’s 
emotions regarding the disorder, and the functional aspect evaluates how the disorder is affecting 
the patient’s ability to perform daily tasks (Jacobson, Johnson, Grywalski, Silbergleit, Jacobson, 
Benninger et al., 1997).  The instrument is composed of 30 items which are based on a five-point 
scale (0 is never, 1 is almost never, 2 is sometimes, 3 is almost always and 4 is always).  The 
total VHI score may range from 0 to 120; 120 is considered to be most severe.   
Jacobsen et al (1997) used the World Health Organization’s definitions for “disability” and 
“handicap” when designing the Voice Handicap Index.  They applied the definition for 
disability, which is “a restriction or lack of ability manifested in the performance of daily tasks” 
to a voice disability which would be a patient’s inability to perform a certain vocal task (p. 66).  
Also, they believed that a voice handicap existed when a patient experienced “a social, 
economic, or environmental disadvantage” due to his voice disability.  Hapner et al. (2007) 
discovered that the mean pretreatment VHI score for patients who dropped out of voice therapy 
was actually higher than those who completed it but that this difference was not significant.  
However, no study has attempted to analyze the use of the VHI subtest scores as predictors of 
patient adherence or compliance with voice therapy. In addition to demographic variables and 
patient health status, the present study will examine the significance of patients’ scores on the 
physical, emotional and functional 10-item sub-scales of the Voice Handicap Index. The 
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present study will also assess whether individual questions on the VHI as well as combinations 
of questions will predict patient compliance/adherence to voice therapy.  These questions will 
fall under one of the three categories previously mentioned, comprised of physical, functional 
and emotional items.  Due to the evidence suggesting that increased vocal use is associated with 
occupational risk for voice problems (Roy et al. 2005); the present study will address the 
relationship between the functional items of the VHI and patient compliance/adherence.  
Understanding the reasons for patient noncompliance or nonadherence to voice therapy will aid 
SLPs in providing better healthcare for their voice patients (Portone et al., 2008).  The ability to 
better determine who will adhere to voice therapy may enable clinicians to distribute their 
services among patients who will benefit most from these services, thus saving time and 
resources. 
 Other tools exist to measure patient perception of voice disorders.  The World Health 
Organization has approved a perceptual assessment that consists of 28 items using the 
International Classification of Impairments, Disabilities, and Handicaps-2 Beta-1 Concept 
(WHO, 1997).  According to Ma and Yiu (2001), this tool allows the patient to report her 
perception of her voice disorder as well as her “limitation” and “restricted participation” in daily 
voice activities (p. 511).  Ma and Yiu’s (2001) study revealed that, using this perceptual 
assessment, a group of 40 dysphonic participants reported more severe voice problems, increased 
limitation in everyday activities and more restricted participation in everyday activities than 40 
individuals in the control group.  However, this study also showed that the patient’s perception 
as indicated by this tool was not positively correlated with the clinician’s perception or acoustic 
measures of the voice disorder.  Therefore, the VHI was used for the purposes of this study. 
 
10 
 
Time and Adherence to Therapy 
A recent study completed by Portone-Maira et al (2010) revealed that temporal variables 
may be indicators of patient dropout or adherence to voice therapy.  These variables include: 
duration between referral by otolaryngologist and initial voice therapy evaluation, duration 
between voice evaluation and the first follow-up therapy session, the number of sessions 
attended, the number of cancellations, and the time from the initial to the final therapy session.  
This study was conducted via retrospective chart review.  Results indicated that the mode for 
number of sessions of those who completed therapy was four sessions.  Also, the researchers 
discovered that fewer days between the otolaryngologist’s referral and the initial evaluation with 
the SLP predicted therapy completion.   
 
Rationale for the Present Study 
 
Many research studies about voice therapy have indicated that patient withdrawal from 
voice therapy has been a problem.  The rate of patient dropout from voice therapy, as previously 
mentioned, is high and often causes frustration for voice therapists (Hapner et al., 2007).  In 
addition, it negatively impacts costs to healthcare and research outcomes (Portone et al., 2006).  
Research in the past has attempted to identify predictor variables that may aid clinicians in better 
identifying patients that are most likely to drop out or be nonadherent to voice therapy.  Current 
and future research regarding this matter should also look into the effects of demographic 
variables and patient perception on patient compliance and adherence to voice therapy. 
 This study seeks to discern the relationship between numerous personal variables and 
patient noncompliance and nonadherence to voice therapy.  These variables include: age, gender, 
driving status, smoking status, diagnosis of acid reflux, diagnosis during voice evaluation, 
insurance type, occupation, distance from the clinic, and the number of days between the 
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stroboscopy appointment and the SLP’s perceptual voice evaluation. Although no significant 
relationship was found to exist between the total VHI score and patient noncompliance in the 
previous study by Hapner et al. (2007), the present study seeks to examine if the sub-scale scores 
or ratings of individual questions of the VHI correlate with patient noncompliance. 
This study aimed to address the following research questions:  
(1) Do VHI scores on individual question items aid in predicting compliance to therapy? 
(2) Do VHI subtest scores (emotional, functional, or physical) aid in predicting 
 compliance to therapy? 
(3) Do personal variables (e.g., age, gender, occupation, etc.) aid in predicting 
compliance  to therapy? 
(4) Does a combination of VHI scores (total and subtests) and personal variables better 
 predict compliance to therapy? 
The hypotheses for this study include: 
  (1) VHI question items receiving less severe patient ratings (scores of 0, 1 or 2) will aid 
 in predicting patient noncompliance to therapy. 
  (2) The VHI subtest of Functional items will have the most predictive value on patient 
 compliance to voice therapy. 
 (3) Increased VHI total and subtest scores will aid in predicting those that are more likely 
 to comply. 
 (4) Personal variables of driving status, insurance type, and driving distance when paired 
 with VHI overall and subtests scores will best aid in predicting patient compliance.    
CHAPTER II 
 
METHODOLOGY 
 
Participants 
 
 Twenty-five adult patient-participants were recruited for the present study (6 male and 19 
female).  Participants were over the age of 18 years old.  All participants were first-time patients 
seen at Eastern Carolina ENT (ECENT) or ECU Speech-Language and Hearing Clinic 
(ECUSLHC) in Greenville, North Carolina who voluntarily presented to the clinic.  All patients 
over the age of 18 who presented for a first-time voice evaluation at ECENT or ECUSLHC were 
given the opportunity to participate.  All participants whose data was used for this study had 
never before been diagnosed with a voice disorder nor have had a voice evaluation, and had 
never seen or used the Voice Handicap Index (Appendix A) prior to this study.  Participants were 
identified only because they were scheduled for a voice evaluation.  This means that they were 
referred from an outside source to evaluate for the presence of a voice disorder.  Participants who 
were subsequently referred for voice therapy after the initial evaluation were followed over the 
course of their entire treatment in order for the researchers to measure compliance. 
Selection of Participants 
 The participants were informed of this study when they presented to Eastern Carolina 
ENT or ECUSLHC for a voice evaluation for the first time.  Patients interested in becoming 
participants of this study were required to complete an informed consent document (Appendix B) 
that was provided by the speech-language pathologist (SLP) or graduate student researcher.  The 
data of those patients who were scheduled to return for an appointment for voice therapy was 
included in this study.  Those who reported a history of voice disorders, received prior voice 
therapy, or had seen or used the Voice Handicap Index (VHI) before were eliminated from this 
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study.  Patients were not excluded for any reason associated with age, gender, race, ethnicity, 
occupation, other co-morbid health issues, or smoking status. 
Operational Definitions 
 No solitary definition for voice disorders has been determined (Verdolini and Ramig, 
2001).  For the purpose of this study, voice disorder is defined as a voice problem that has been 
diagnosed by an otorhinolaryngologist (ENT) and has been contributed to an organic, functional 
or neurological change in the voice that is negatively impacting a patient. 
  For the purposes of this study, voice therapy is defined as non-surgical intervention 
directed by an SLP that may and typically does include vocal exercises and techniques designed 
to decrease patient discomfort while attempting to increase appropriate use of the voice.  Voice 
therapy may also include education to minimize harmful vocal habits.  Typically, voice therapy 
is individualized to each patient.   
 The operational definitions for compliance and noncompliance for this study are similar 
to those reported by Hapner et al. (2007).  Compliance is defined as regular attendance to 
scheduled voice therapy sessions as well as the adherence to voice therapy techniques that are 
recommended by the SLP.  Therefore, 2 different types of compliance measurements have been 
collected (attendance and adherence).  Noncompliance (or dropout) is considered to be: 1) 
failure to present for the first voice therapy session, 2) discontinuation of therapy without a 
clinician’s consent, or 3) discontinuation of therapy due to failure to meet therapy objectives (to 
be determined by the SLPs). 
Procedures 
 Prior to informing a patient of this study, the SLP determined if the patient met the age 
criteria for participation.  Participants were informed that the purpose of this study is to analyze 
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the individual components of the Voice Handicap Index; however, the participants were not 
notified that the study will be assessing their compliance with voice therapy as this may have 
altered the participants’ attendance to voice therapy, therefore distorting the data results.  The 
VHI was sent to possible participants via mail.  For possible participants who did not receive a 
VHI in the mail, the VHI was given prior to stroboscopy so they could document their personal 
perception of their voice before seeing their vocal folds. 
Upon completion of participants’ voice evaluation, the SLP and ENT determined if voice 
therapy was an appropriate treatment recommendation for this patient. Patients were seen by an 
ENT while on-site at ECENT.  Patients at ECU were referred to an ENT at the completion of 
their voice evaluation with the SLP. Once the ENT determined that therapy was appropriate, the 
patient was then enrolled in voice therapy at ECUSLHC.  (The procedures for enrolling patients 
are slightly different at each clinic; however, at both clinics patients were asked to participate by 
an SLP or the student researcher, had an ENT recommendation for voice therapy, and were 
scheduled for therapy as appropriate).  The researchers were not a part of this portion of the 
patient’s experience (i.e., the ENT examination); the researchers only distributed the VHI to the 
patient and then followed the patient’s record (i.e. for compliance) if the SLP indicated the 
patient was enrolled into voice therapy.  Participants for whom voice therapy was recommended 
were included in the present study and the researchers followed their attendance and compliance 
to treatment via chart reviews.  The researchers did not have contact with the participants 
regarding the study after the initial visit where informed consent was obtained and the VHI was 
completed.  The participants who did not need voice therapy were excluded.  The ENT and SLP 
encouraged patients to attend their first scheduled voice therapy session but this is part of the 
usual routine of ECENT and ECUSLHC and is not behavior specifically present because of the 
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present study. 
The VHI was scored by the student researcher and the participants were informed of their 
scores as the SLP deemed appropriate in the course of the patient’s treatment.  The VHI includes 
questions regarding patients’ perception on how their voice affects their life, physically, 
emotionally, and functionally.  The patient may answer these questions using the following five 
descriptors: (0) Never, (1) Almost Never, (2) Sometimes, (3) Almost Always, and (4) Always.   
Questions are divided regarding the type of impairment: physical, emotional, or functional; 
points for each section were added to reveal subtest (physical, emotional, and functional) scores.  
The points for all 30 VHI questions were added to receive a total score which was indicative of 
the perceived level of handicap of the patient participant.  The resulting score could indicate no 
handicap or a mild, moderate, or severe handicap.  No handicap/mild handicap is associated with 
a score of 0 to 30, a moderate handicap is correlated with a score of 31 to 60, and a severe 
handicap is indicated by a score of 61 to 120.   
The use of the VHI in treatment is common and the SLPs used this information as they 
typically do when treating patients with voice disorders.  The data from the VHI as well as 
demographic information was obtained from the chart by the researchers during a file review 
after the evaluation was completed and over the course of therapy.  This data included the post-
evaluation diagnosis, the dates of evaluations, the patient’s ZIP code (to determine driving 
distance), the patient’s driving status, smoking status, presence of acid reflux, occupation, age, 
gender, type of insurance/payment, and the date of dismissal or termination from treatment.  The 
primary investigator rated each patient participant’s smoking status, reflux status, occupation, 
and driving status with a numerical system for each variable.  Smoking status was rated as 
follows: 0= participant never smoked, 1= participant is a former smoker, or 2= participant 
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continues to smoke.  Reflux status was rated using the following scale: 0= participant has never 
been diagnosed with reflux, 1= participant was formerly diagnosed with reflux, or 2= participant 
was diagnosed with reflux during today’s stroboscopy appointment.  Occupation was rated as 
follows: 0= participant is unemployed or retired, 1= participant works part-time, or 2= 
participant works full-time.  Driving status was divided into: 0= participant is an independent 
driver, 1= family member or friend drives participant, 2= participants relies on public 
transportation, or 3= participant relies on medical transportation. 
After administration of the VHI, if voice therapy was recommended for the participants, 
their attendance and adherence to therapy was tracked.   
Summary of Explanatory Variables 
 The explanatory variables for this study included the total score as well as the subtest 
scores for the VHI.  In addition to these data, the following information was collected through 
the chart reviews: age, gender, driving status, ZIP code, post-evaluation dysphonia diagnosis, 
presence of reflux, type of insurance/payment, smoking status, occupation, and therapy dates (to 
count number of sessions attended).  Insurance types were categorized into: no insurance, 
Medicare, Medicaid, private or military.  The researchers also reviewed the chart notes to 
determine the final date the patient was dismissed, terminated, or discontinued therapy as well as 
the reason for therapy ending.  Driving distance was calculated by putting the patient ZIP code 
and the clinic’s ZIP code into an Internet based map service, www.mapquest.com.  Lastly, the 
researchers reviewed the therapy notes to determine if the patient was demonstrating adherence 
to therapy recommendations. 
 Adherence was measured by the researcher after the patient completed a treatment 
session.  The number of treatment sessions that each participant attended was recorded by the 
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investigators. Adherence was rated for each treatment session. Adherence was rated on a 4 point 
scale by the researchers.  A 3 indicated the patient was completely adherent to recommendations, 
a 2 indicated that the patient was moderately adherent to recommendations, a 1 indicated that the 
patient was mildly adherent and a 0 indicated the patient was non-compliant in adhering to 
recommendations.  A 0 was given if the patient attended therapy, but did not carry out the 
therapy assignments as recommended.  Participants who did not show for their first treatment 
session were given a 0 rating for adherence because technically therapy never began.  The 
termination reason was also recorded and categorized according to whether the patient 
experienced gains from treatment or not (“gains” versus “no gains”).  If the patient experienced 
gains from treatment, a 1 ( which indicated “therapy completed, clinician dismissal”) or a 2 
(“patient requested dismissal because he/she perceives therapy completed”) was assigned.  
However, a 3 (indicating “patient experienced no gains, therapy terminated”), a 4 (“patient did 
not participate/no show for first session”) or a 5 (“patient stopped coming to treatment”) was 
assigned to participants who did not experience gains from therapy. 
Data Analysis 
Descriptive statistics were used to describe all explanatory variables.  Frequencies, 
percentages, means, medians, and standard deviations were calculated when appropriate.  Due to 
the limited sample size, inferential analysis was not used to analyze all data.  However, Pearson 
correlation and two-tailed t-tests were used to determine if a statistical difference could be found 
between adherence rating and the following variables: VHI total and subtest scores, miles from 
Greenville, and age. 
CHAPTER III 
DEPENDENT AND INDEPENDENT VARIABLES AND STATISTICAL  
TREATMENT OF THE DATA 
The present study measured the participants’ adherence to recommendations for voice 
therapy in comparison to personal and demographic information, and the patients’ perceived 
handicap related to their voice disorder prior to undergoing stroboscopy.  The following 
explanatory variables were defined: Voice Handicap Index (VHI) total scores and subtest scores, 
as well as individual VHI questions; demographic information including age, gender, driving 
status, distance from clinic (using ZIP code), post-evaluation dysphonia diagnosis, presence of 
reflux, type of insurance or payment, smoking status, occupation, and number of sessions 
attended; and adherence ratings to therapy recommendations (0= completely nonadherent/did not 
show for therapy, 1= mildly adherent , 2= moderately adherent, 3= completely adherent).   
 Due to a lower than expected number of subjects, descriptive statistics were used to 
account for all explanatory variables.  Dependent variables were described with the mean, 
median, and standard deviations.  Adherence ratings to therapy recommendations (values of 0-3) 
were collapsed into two categories: adherent and nonadherent.  Repeated measures two-tailed t-
tests were used to determine if there was statistical significance in the correlation between 
adherence rating and variables such as VHI total and subtest scores, age, and miles from 
Greenville.  A Pearson correlation was applied. 
Participants’ Perceptions of their Voices 
Adherence was compared to the mean and standard deviations of the participants’ total 
VHI scores and subtest scores. 
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Table 1 
VHI Total Score and Subtest Scores 
 
Adherence 
VHI  
Total  
VHI  
Physical 
VHI 
Emotional 
VHI 
Functional 
Nonadherent N  16 17 19 17 
Mean 42.9 18.7 10.6 13.6 
Median 45.0 18.0 11.0 14.0 
Std. Deviation 20.4 8.05 7.04 7.04 
Adherent N  6 6 6 6 
Mean 40.0 19.2 9.3 11.5 
Median 31.0 17.5 6.0 8.0 
Std. Deviation 23.8 5.2 10.5 9.6 
 
Table 1 illustrates the data for the VHI total scores and subtest scores.  The mean score 
for the VHI total score was 42.9 (SD = 20.4) for the nonadherent group and for the adherent 
group was 40 (SD = 23.8). The mean score on VHI physical subtest score for the nonadherent 
group was 18.7 (SD = 8.05) and 19.2 (SD of 5.2) for the adherent group. The mean for the 
nonadherent group’s VHI emotional subtest score was 10.6 (SD = 7.04) and 9.3 (SD = 10.5) for 
the adherent group.  The mean for the VHI functional subtest score for the nonadherent group 
was 13.6 (SD= 7.04) and was 11.5 (SD= 9.6) for the adherent group.   
Participant’s Responses to VHI Questions 
Each of the 30 individual VHI questions was analyzed separately for the mean, median, 
and standard deviation.  Participant responses were divided into two groups: “nonadherent” and 
“adherent.” 
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Table 2 
Comparison of VHI Physical Questions and Adherence 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 outlines the data for the individual scores on the VHI for the adherent and 
nonadherent groups for questions in the Physical subtest.  This included questions 2, 4, 10, 13, 
14, 17, 18, 20, 21, and 26.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Adherence Q2 
 
Q4 
 
Q10 
 
Q13 
 
Q14 
 
Nonadherent N      
Mean 
Median 
Std. Dev. 
19 
1.9 
2.0 
.96 
19 
1.95 
2.0 
.9 
18 
1.92.0 
1.2 
19 
2.1 
2.0 
1.3 
19 
2.2 
2.0 
1.1 
Adherent N      
Mean 
Median 
Std. Dev. 
6 
1.8 
2.0 
.41 
6 
2.0 
2.0 
1.1 
6 
2.2 
2.0 
.41 
6 
2.2 
2.5 
1.2 
6 
2.5 
2.0 
.84 
Adherence Q17 
 
Q18 
 
Q20 
 
Q21 
 
Q26 
 
Nonadherent N      
Mean 
Median 
Std. Dev. 
19 
.95 
1.0 
1.1 
18 
1.6 
2.0 
1.2 
19 
1.8 
2.0 
1.2 
18 
1.8 
2.0 
1.2 
18 
2.3 
2.0 
.89 
Adherent N      
Mean 
Median 
Std. Dev. 
6 
1.2 
1.5 
.98 
6 
1.5 
2.0 
1.2 
6 
1.5 
1.0 
1.8 
6 
2.0 
2.0 
.63 
6 
2.5 
2.0 
.52 
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Table 3 
 Comparison of VHI Emotional Questions and Adherence 
 
Adherence 
Q7 
 
Q9 
 
Q15 
 
Q23 
 
Q24 
 
Nonadherent N  19 19 19 19 19 
Mean 1.5 1.2 1.9 .74 1.0 
Median 2.0 1.0 2.0 0 1.0 
Std. Deviation 1.2 .90 1.3 1.05 1.16 
Adherent N  5 6 6 6 6 
Mean 1.2 1.6 1.8 .83 .83 
Median .5 2.0 2.0 .0 .0 
Std. Deviation 1.5 1.1 .98 1.33 1.33 
 
 
 
 
 
 
Table 3 illustrates the data for the individual scores on the VHI for the adherent and 
nonadherent groups for questions in the Emotional subtest.  This includes questions 7, 9, 15, 23, 
24, 25, 27, 28, 29, and 30.  Several of the mean scores equal less than 1.0 which is due to the 
presence of ratings of 0 in the data sample.   
 
 
 
 
 
 
 
 
 
Adherence Q25 
 
Q27 
 
Q28 
 
Q29 
 
Q30 
 
Nonadherent N      
Mean 
Median 
Std. Dev. 
19 
1.11 
1.0 
.99 
19 
.89 
1.0 
.94 
19 
.53 
0 
.84 
19 
.74 
0 
1.15 
19 
1.0 
1.0 
.88 
Adherent N      
Mean 
Median 
Std. Dev. 
6 
.67 
0 
1.2 
6 
.5 
0 
1.23 
6 
.5 
0 
1.23 
6 
.5 
0 
1.23 
6 
1.2 
1.0 
1.33 
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Table 4 
 Comparison of VHI Functional Questions and Adherence 
 
Adherence 
Q1 
 
Q3 
 
Q5 
 
Q6 
 
Q8 
 
Nonadherent N            18 18 19 19 19 
 Mean 1.8 2.2 1.5 1.8 1.2 
 Median 2.0 2.0 2.0 2.0 1.0 
 Std. Deviation .81 1.1 1.3 1.2 1.02 
Adherent N             6 6 6 6 6 
 Mean 2.2 1.8 1.33 1.5 .83 
 Median 2.0 2.0 1.0 2.0 .0 
 Std. Deviation .41 .98 1.51 1.23 1.33 
 
 
 
 
 
 
Table 4 displays the data for the individual scores on the VHI for the adherent and 
nonadherent groups for questions in the Functional subtest.  This includes questions 1, 3, 5, 6, 8, 
11, 12, 16, 19, and 22.   
 
Demographic Information and Adherence to Therapy Recommendations 
Tables 5-12 display the data for the explanatory variables and adherence to therapy 
recommendations.   
 
 
 
Adherence Q11 
 
Q12 
 
Q16 
 
Q19 
 
Q22 
 
Nonadherent N      
Mean 
Median 
Std. Dev. 
19 
1.1 
1.0 
1.1 
19 
1.5 
2.0 
.91 
19 
.89 
1.0 
.94 
19 
1.0 
1.0 
1.16 
19 
.11 
0 
.46 
Adherent N      
Mean 
Median 
Std. Dev. 
6 
.83 
0 
1.33 
6 
1.33 
1.5 
1.2 
6 
.83 
0 
1.33 
6 
.83 
0 
1.33 
6 
0 
0 
0 
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Age 
Table 5 
Participant Age in relation to Adherence 
 
 
 
 
 
 
 
 
Table 5 displays the following data.  The mean age for participants in the nonadherent 
group was 56.4 years (SD= 14.9 years) and the mean age for participants in the adherent group 
was 58.5 years (SD= 9.9 years).  
Gender 
Table 6 
Gender Compared with Adherence 
 
 Gender 
 Male Female 
Nonadherent Frequency (%) 4 (21.1%) 15 (78.9%) 
Adherent 
 
Frequency (%) 2 (33.3%) 4 (66.7%) 
 
Table 6 demonstrates the gender breakdowns.  Four participants (21.1%) in the 
nonadherent group were male and 15 (78.9%) were female.   In the adherent group, two 
participants (33.3%) were male and four (66.7%) were female. 
 Age 
Nonadherent 
N = 19 
Mean 56.4 
Median 59.0 
Std. Deviation 14.9 
Adherent 
N = 6 
Mean 58.5 
Median 59.5 
Std. Deviation 9.9 
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Smoking and Reflux 
Table 7 
Smoking Status and Reflux Status in relation to Adherence 
 
 Smoking Reflux 
Never 
Smoked 
Former 
Smoker 
Continues 
to Smoke 
Never 
Diagnosed 
Previously 
Diagnosed 
Diagnosed 
during 
Stroboscopy 
Nonadherent 
 
Frequency 
(%) 
10(52.6%) 5(26.3%) 4 (21.1%) 3 (15.8%) 12(63.2%) 4 (21.1%) 
Adherent Frequency 
(%) 
3 (50%) 3 (50%) 0 1 (16.7%) 4 (66.7%) 1 (16.7%) 
 
Table 7 illustrates the percentages of nonadherent and adherent participants who fell into 
the following categories for smoking status: never smoked, former smoker, or continues to 
smoke.  It also demonstrates percentages of participants in the following reflux categories: never 
diagnosed, previously diagnosed, or diagnosed during stroboscopy. 
Driving status 
Table 8 
Participant Driving Status and Adherence to Therapy 
 
 
 
 
Driving Status 
Independent 
Driver 
Family/Friend 
Drives 
Public 
Transportation 
Medical 
Transport 
Nonadherent Frequency (%) 14 (73.7%) 4 (21.1%) 0 1 (5.3%) 
Adherent Frequency 6 (100%) 0 0 0 
 
Table 8 indicates the driving status of nonadherent and adherent participants. 
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Distance from the Clinic 
Table 9 
Driving Distance from Greenville in comparison to Adherence 
 
 
 
 
 
 
 
 
Table 9 illustrates information regarding driving distance from the clinic and participant 
age.  The mean number of miles from Greenville, NC was 29.2 (SD= 19.6) for the nonadherent 
group and 44.6 (SD= 23.6) for the adherent group.   
Insurance and Occupation 
The primary investigator reviewed the participant charts for information regarding their 
primary and secondary insurance, and then rated the types of insurance according to the 
following: 1= Medicare, 2= Medicaid, 3= Private, 4= self-pay, and 5= Military. 
 
 
 
 
 
 
 
 
 
 
 
 
 Driving 
Distance 
Nonadherent 
N = 19 
Mean 29.2 
Median 39.5 
Std. Deviation 19.6 
Adherent 
N = 6 
Mean 44.6 
Median 39.7 
Std. Deviation 23.6 
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Table 10 
Insurance and Occupation in relation to Adherence 
 
Table 10 illustrates the data relating to insurance and occupation.   
Patient Attendance and Adherence to Therapy Recommendations 
The number of treatment sessions for participants ranged from 0 to 13 sessions.  The 
mean number of sessions for participants in the adherent group was 4 (SD= 4.5) and the mean 
number of sessions for the nonadherent participants was .42 (SD= .77).  The mean adherence 
rating completed by the SLPs for the nonadherent group was 0 and the mean of 2.5 (SD of .84) 
was determined for the adherent group.  The mean rating for termination reason was 4.1 (SD= 
.23) for the nonadherent group and the adherent group’s mean rating was 2.2 (SD= 1.5).  
  Occupation 
  Unemployed/ 
Retired 
Part-time Job Full-time Job 
Nonadherent Frequency 
(%) 
12 (63.2%) 0 7 (36.8%) 
Adherent Frequency 
(%) 
5 (83.3%) 1 (16.7%) 0 
 Primary Insurance 
Medicare Medicaid Private Self-pay Military 
Nonadherent Frequency (%) 6 (31.6%) 2(10.5%) 10(52.6%) 1 (5.3%) 0 
Adherent Frequency (%) 4 (66.7%) 0 2 (33.3%) 0 0 
 Secondary Insurance 
 Medicare Medicaid Private Military None 
Nonadherent Frequency(%) 1 (5.3%) 0 4 (21.1%) 1 (5.3%) 13(68.4%) 
Adherent Frequency(%) 0 1 (16.7%) 0 0 5(83.3%) 
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Diagnosis and Adherence 
Patients at the clinic are typically given primary, secondary, and tertiary diagnoses when 
appropriate.  Several participants did not have secondary and/or tertiary diagnoses. All 
participants involved in the present study received a primary diagnosis at their initial stroboscopy 
appointment as this was a criterion for inclusion into this study.   
Table 11 
Comparison of Diagnosis and Adherence 
            Primary         Secondary    Tertiary 
Adherence Frequency Percent Frequency  Percent Frequency Percent 
Nonadherent 
Dysphonia 
TVF nodules 
MTD 
LPR 
Myasthenia 
Reinke’s edema 
TVF paralysis 
Chronic Cough 
Tracheal inflammation 
Laryngeal tremor 
No Diagnosis 
Total 
 
10 
3 
1 
2 
3 
0 
0 
0 
0 
0 
0 
19 
 
52.6 
15.8 
5.3 
10.5 
15.8 
0 
0 
0 
0 
0 
0 
100.0 
 
4 
1 
0 
7 
3 
1 
1 
2 
0 
0 
0 
19 
 
21.1 
5.3 
0 
36.8 
15.8 
5.3 
5.3 
10.5 
0 
0 
0 
100.0 
 
2 
0 
0 
6 
1 
0 
0 
0 
1 
1 
8 
19 
 
10.5 
0 
0 
31.6 
5.3 
0 
0 
0 
5.3 
5.3 
42.1 
100.0 
Adherent 
Dysphonia 
LPR 
TVF Polyp 
TVF nodules 
SLN weakness 
CVA 
MTD 
No Diagnosis 
Total 
 
1 
2 
1 
0 
0 
1 
1 
0 
6 
 
16.7 
33.3 
16.7 
0 
0 
16.7 
16.7 
0 
100.0 
 
2 
1 
0 
1 
0 
0 
0 
2 
6 
 
33.3 
16.7 
0 
16.7 
0 
0 
0 
33.3 
100.0 
 
0 
0 
0 
0 
1 
0 
0 
5 
6 
 
0 
0 
0 
0 
16.7 
0 
0 
83.3 
100.0 
 
Evaluation Dates and Adherence 
A scale was used to describe the time between each participant’s stroboscopy 
appointment and perceptual evaluation with the speech-language pathologist (SLP).  The 
following descriptors were used in the scale: 0= patient did not schedule or attend SLP 
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perceptual evaluation, 1= SLP perceptual evaluation was within 1 week of stroboscopy date, 2= 
SLP perceptual evaluation was within 2 weeks of stroboscopy date, 3= SLP perceptual 
evaluation was within 3 weeks of stroboscopy date, and 4= SLP perceptual evaluation was 1 
month or more after stroboscopy date.   
Table 12 
Days between Strobe and Perceptual Evaluation  
 
Nonadherent N  19 
Mean 1.00 
Median .00 
Std. Deviation 1.53 
Adherent N  6 
Mean 2.33 
Median 2.00 
Std. Deviation 1.03 
 
Regarding the time between the stroboscopy appointment and the perceptual evaluation, 
the mean for the nonadherent group was 1.0 week (SD= 1.53) whereas the mean for the adherent 
group was 2.33 weeks (SD= 1.03).  This information is demonstrated in Table 12. 
A scale similar to the one used above was also used to describe the time between each 
participant’s appointment with their physician who referred them for stroboscopy and the 
stroboscopy appointment.  The descriptors were modified in the scale to read as follows: 0= no 
referral date indicated in the chart, 1= stroboscopy appointment was within 1 week of referring 
physician date, 2= stroboscopy appointment was within 2 weeks of referring physician date, 3= 
stroboscopy appointment was within 3 weeks of referring physician date, and 4= stroboscopy 
appointment was 1 month or more after referring physician date. 
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Table 13 
Days between Referral and Stroboscopy Appointment 
  
Nonadherent N  19 
Mean .79 
Median .00 
Std. Deviation 1.4 
Adherent N  6 
Mean 1.7 
Median 1.50 
Std. Deviation 1.9 
 
The mean for the nonadherent group was .79 week (SD= 1.4) and the mean for the 
adherent group was 1.7 weeks (SD= 1.9).  This data is illustrated in Table 13.  
Pearson Correlation and T-tests 
Table 14 
P-values and Pearson Correlation 
 
 
  Adherence 
Rating 
Age  Pearson Correlation 
Sig. (2-tailed) 
N 
-.016 
.938 
25 
Miles from Greenville Pearson Correlation 
Sig. (2-tailed) 
N 
.338 
.099 
25 
VHI Total Score Pearson Correlation 
Sig. (2-tailed) 
N 
.031 
.890 
22 
VHI Physical Subtest 
Score 
Pearson Correlation 
Sig. (2-tailed) 
N 
.106 
.630 
23 
VHI Emotional 
Subtest Score 
Pearson Correlation 
Sig. (2-tailed) 
N 
.032 
.881 
25 
VHI Functional 
Subtest Score 
Pearson Correlation 
Sig. (2-tailed) 
N 
-.053 
.809 
23 
30 
 
  
 Variables that were expected to demonstrate a trend were further analyzed using Pearson 
correlation and two-tailed t-tests.  Table 14 demonstrates the following data.  The correlation 
between adherence rating and VHI total scores is small (.031) and the p-value is large (.890).  
Therefore, no correlation was found to exist between these variables.  In addition, no correlation 
was found to exist between adherence rating and VHI subtests scores or age.  However, there is a 
moderate correlation between adherence rating and miles from Greenville. 
CHAPTER IV 
DISCUSSION 
The purpose of the present study was to determine if explanatory variables such as VHI 
scores, responses to VHI questions, and demographic information would predict patient 
attendance and/or adherence to recommendations for voice therapy.  Prior to data collection, the 
investigators formed several hypotheses.  The first research question was to determine if VHI 
questions that received less severe patient ratings (scores of 0, 1, or 2) would predict a 
participant’s nonadherence to therapy.  The second research question was developed to 
determine if the VHI Functional subtest would have the most predictive value on patient 
compliance to voice therapy.  The third research question was to determine if more severe VHI 
total and subtest scores would correlate with participants who received a higher adherence rating.  
Lastly, it was estimated that explanatory (personal) variables of driving status, insurance type, 
and driving distance when paired with the VHI total and subtest scores would predict patient 
compliance. 
Gender and Age 
Most participants in both the adherent and nonadherent groups were female.  This 
correlates with previous research findings regarding gender of patients who seek medical advice 
(Cleary, Mechanic & Greenley, 1977; Nathanson, 1977; Hibbard & Pope, 1986; Herrington-Hall 
et al., 1988) and of those who seek advice for voice disorders (Hapner et al., 2007).   
Portone et al. (2008) found that the age group in their study who was most likely to attend 
the first voice therapy session was the 21-40 year old age group, and the least likely to attend 
were the 40-64 year olds.  In the present study, the mean age for the adherent group was 
approximately 2 years more than the mean age of the nonadherent group.  The ages for the 
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nonadherent group ranged from 26- 74 years whereas the ages for the adherent group ranged 
from 42-72 years.  This suggests that older individuals may be more likely to comply with 
recommendations for therapy than a younger population but further research is needed to support 
this hypothesis. 
Attendance and Adherence to Voice Therapy 
Portone et al. (2006) found that 38% of patients did not comply with a laryngologist’s 
referral to return for a voice evaluation and 47% who attended a voice evaluation did not attend 
therapy.  The present study had similar outcomes: 12 out of 25 participants (48%) did not return 
comply with the recommendations to return for a voice evaluation and, of the 13 participants 
who did return for a voice evaluation, 38% of these participants did not show for the first therapy 
session.  The mean rating for termination reason for the nonadherent group was 4 which 
indicated that most participants in this group did not even attend the perceptual evaluation.  The 
mean rating for the adherent group was approximately 2 which indicated that most participants in 
this group discontinued therapy due to personal satisfaction with therapy outcomes.  No 
significant correlation was found to exist between adherence rating and age in the present study.  
Further research is warranted to find out if there are underlying reasons for lack of patient 
compliance to voice therapy recommendations. 
 Although previous studies have measured the amount of patient dropout from therapy, 
none have measured the amount of time between the initial referral and the stroboscopy 
appointment.  The present study looked at the time between the initial referral and the actual 
stroboscopy appointment to see if this would be an indicator of therapy adherence/nonadherence.  
It should be noted that the mean time between these appointments for the nonadherent group was 
approximately 1 week but it was approximately 2 weeks for the adherent group.  It may be 
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possible that patients who are more likely to attend voice therapy schedule appointments farther 
in advance than patients who will be nonadherent. 
VHI Total Scores as Predictor of Attendance and Adherence 
This preliminary study was designed to develop a prospective method for investigating 
numerous variables about patients and patient care to determine if any predictions can be made 
about the success of completion of voice therapy.  Due to the prospective nature of this study, 
and several confounding variables with patient recruiting to be discussed later, fewer than 
expected patients were enrolled in the study.  Therefore, inferential statistics were not applied to 
all variables as the power analysis did not reveal enough strength to allow adequate interpretation 
of data.  However, variables that were suspected of demonstrating a trend were further analyzed 
using Pearson correlation and two-tailed t-tests. 
When inspecting the means of the adherent and nonadherent groups relative to the total 
VHI scores, it is clear that there is very little practical or statistical difference between the data.   
Interestingly, the nonadherent participants did rate themselves with less severe handicap in some 
instances: 3 of the nonadherent participants had a VHI score less than 20 whereas none of the 
adherent group had a score less than 20.  Also, the participant with the highest total VHI score 
fell into the adherent group.   Three participants in the nonadherent group received total VHI 
scores that fell within the range of no handicap/mild handicap (scores less than 30), whereas the 
total scores of two participants in the adherent group fell into this range.  Nine participants in the 
nonadherent group received total VHI scores that indicated moderate handicap, whereas the total 
scores of three participants of the adherent group fell into this scoring range.  Four participants of 
the nonadherent group received severe handicap total VHI scores and one participant in the 
adherent group obtained a score in the severe handicap range.  The mean VHI total score fell 
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within the category of moderate handicap for both the nonadherent and the adherent groups.  
Thus, in the present study, the VHI total score did not differentiate the two groups: adherent and 
nonadherent. 
VHI Subtest Scores as Predictor of Attendance and Adherence 
 Hapner et al. (2007) discovered that the mean pretreatment VHI score for patients who 
dropped out of voice therapy was actually higher than the score of those who completed therapy 
but this difference was not significant.  In the present study, the mean pretreatment VHI total 
score for participants who were nonadherent to recommendations for voice therapy was higher 
than those who were adherent.  However, upon inspection of the means, there appears to be no 
clinical or statistical significance in predicting adherence to therapy.  These findings may 
indicate that patients who are nonadherent may overestimate the severity of their voice disorder 
prior to viewing their vocal folds via stroboscopy.  It may be possible that they become relieved 
to find out that they do not have a life-threatening condition and do not perceive a need for voice 
therapy.  Further empirical evidence is needed to support this hypothesis. 
 The means of the VHI Emotional and Physical subtest scores for the nonadherent group 
were approximately one point higher than for the adherent group.  Interestingly, the mean of the 
VHI Functional subtest scores was approximately two points higher for the nonadherent group 
than for the adherent group.  No significant correlation was found between adherence rating and 
VHI subtests scores.  These results did not support the hypothesis that the VHI Functional 
subtest score would have more predictive value on patient adherence to voice therapy than the 
other VHI subtest scores.   
VHI Individual Questions and Adherence 
 No practical difference was found to exist between the two groups’ mean responses to 
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individual questions in the VHI Physical, Emotional, and Functional subtests.  Marginal 
differences, if any, were found to exist between the mean of the responses between the 
nonadherent group and the adherent group.     
Demographic Variables and Adherence 
 Most participants in the nonadherent group indicated that they never smoked (52.6%) 
while 26.3% were former smokers and 21.1% were current smokers.  In the adherent group, 50% 
had never smoked and 50% were former smokers.   In the nonadherent group, most participants 
(63.2%) were formerly diagnosed with reflux (prior to their stroboscopy appointment); whereas 
15.8% had never been diagnosed with reflux and 21.1% were diagnosed with reflux during the 
stroboscopy appointment.  In the adherent group, most participants were formerly diagnosed 
with reflux (66.7%), one participant (16.7%) was never diagnosed, and one participant (16.7%) 
was diagnosed at the stroboscopy appointment.  Thus, it appears that these two important organic 
effects on the vocal folds were present in both groups in a similar degree.  Therefore, it would be 
likely that as participants are added to the population, these two variables may continue not to 
differentiate the two groups.  Although previous studies have researched the benefits of vocal 
hygiene education, none have explored the effects of smoking status and/or reflux upon patient 
completion of voice therapy.   
 In this study, twelve participants (63.2%) in the nonadherent group did not have a job; no 
participants held a part-time job, and seven (36.8%) held a full-time job.  Five participants 
(83.3%) in the adherent group were unemployed or retired, and one participant (16.7%) held a 
part-time job.  The adherent group did not have any full-time workers whereas the nonadherent 
group did have seven full time workers.  While the lack of statistical analysis prevents strong 
conclusions, this may be one indicator that individuals with full time employment may have a 
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more difficult time adhering to a therapy program.  However, since most participants in both the 
nonadherent and the adherent group were unemployed or retired, this data may indicate that 
those who do not hold a job have difficulty attending therapy (possibly due to financial barriers).  
Important variables that were explored in the present study were ones that have a direct effect on 
the ability of patients to even attend therapy – let alone adhere to therapy recommendations by 
practicing exercises.  If participants are not able to physically travel to therapy because they do 
not have reliable transportation, they may be noncompliant simply because they are unable to 
make it to the clinic.  Similarly, a client could be highly motivated to come to therapy, but 
without insurance or affordable co-pays for example, the client may be a non-attender because of 
finances.  Thus, in the present study, distance from the clinic and type of insurance were 
investigated to determine if differences in these variables contributed to adherence.  
 Most participants (31.6%) in the nonadherent group used a private insurance company for 
their primary insurance whereas most participants (66.7%) in the adherent group relied on 
Medicare for primary insurance.  Most participants in both groups did not rely on any type of 
secondary insurance.  Of those who did rely on secondary insurance within the nonadherent 
group, most (21.1%) relied on a private insurance company.  The only participant to use 
secondary insurance in the adherent group used Medicaid.  This information suggests that 
participants who rely on government-funded insurance may participate more in therapy.  
However, more evidence is needed to confirm this hypothesis. 
 In the nonadherent group, 14 participants (73.7%) were independent drivers, four 
(21.1%) depended upon a friend or family member to drive to appointments, and one (5.3%) 
relied on medical transport for appointments.  All six participants (100%) in the adherent group 
were independent drivers.  Most participants in both groups (nonadherent and adherent) were 
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independent drivers.  Therefore, even with a larger participant pool, driving status may not be a 
strong indicator of patient adherence to therapy.  However, the five participants in the 
nonadherent group who were not independent drivers may have been prevented from attending 
therapy due to their reliance on other drivers. 
 Interestingly, the mean number of miles from Greenville was 15 miles more for the 
adherent group than the nonadherent group.  A moderate correlation was found to exist between 
miles from Greenville and adherence rating.  It would seem as though participants who lived 
further from the clinic would be less likely to adhere to recommendations for therapy due to the 
driving distance but this was not the case, according to data from this study.  Greenville, while 
technically classified as a city, is a more rural location. There are vast outlying areas where there 
are no SLP services, let alone a specialized SLP clinic like an ENT office.  Thus, it is possible 
than the patients who were driving greater distances were more motivated to find a specialist 
because there may not be one in the local area whereas individuals living closer may believe that 
they can reschedule their appointments more easily because the ENT clinic is simply more 
accessible.   
 In a previous study completed by Hapner et al. (2007), diagnosis was divided into 
“hypofunctional” and “hyperfunctional” categories.  Although 29.3% of their participants had 
“hypofunctional” voice disorders and 70.7% had “hyperfunctional” disorders, these categories 
were not found to have any significant value in predicting therapy completion or dropout.  In the 
present study, most participants (52.6%) in the nonadherent group were given the primary 
diagnosis of dysphonia, followed by laryngopharyngeal reflux (15.8%) and true vocal fold 
nodules (15.8%).  Most participants in the adherent group (33.3%) were given the primary 
diagnosis of laryngopharyngeal reflux.  For secondary diagnosis, most participants in the 
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nonadherent group (36.8%) had laryngopharyngeal reflux whereas most participants in the 
adherent group had dysphonia (33.3%).  Six participants (31.6%) in the nonadherent group 
presented with laryngopharyngeal reflux as a tertiary diagnosis.  The only participant (16.7%) to 
have a tertiary diagnosis in the adherent group presented with superior laryngeal nerve weakness.   
 In the present study, results regarding the time between stroboscopy appointments and 
the SLPs’ perceptual evaluations did not agree with results from the study completed by Portone-
Maira (2010) who found that less time between initial referral and SLP voice evaluation 
predicted therapy completion.  However, differences in the amount of data collected in each 
study could contribute to this disparity.  For the nonadherent group in the present study, the mean 
amount of time between these two appointments was approximately 1 week (SD= 1.53).  For the 
adherent group, the perceptual evaluation took place approximately 2.33 weeks (SD= 1.03) later.  
One hypothesis to explain the difference in time is that the participants in the adherent group 
may have looked at their schedules more intently prior to scheduling the perceptual evaluation.  
This may be an indicator that these participants took the physician/SLP’s recommendations for 
voice therapy more seriously than the participants in the nonadherent group. 
Limitations of the Study 
Limitations of this study must be considered before this study is replicated.  The 
administration of the VHI on a regular basis was a new practice for the clinic as the office 
typically used a “hoarseness questionnaire” to obtain patients’ perceptions of their voice prior to 
their appointment.  This questionnaire was not a researched, standardized tool.  More participants 
will be included in the population when the VHI becomes standard practice for all new patients.  
Because the VHI was not a standard form presented to patients at this clinic, missed cases could 
have occurred because the office staff did not regularly request it from patient’s at their first 
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appointment.  A more regular system of administering and collecting the VHI may provide for 
more consistent patient participation in future studies.  The present study was designed to be 
prospective in nature and the prospective nature of this work is a strength.  Further studies should 
aim to develop the clinical practice patterns that allow for stronger data gathering. 
 In addition, the data collection for the present study was largely dependent upon patients 
returning VHIs that were mailed to them.  Therefore, patients not only had to agree to complete 
the VHI but they also had to remember to bring the form to their appointment (prior to 
stroboscopy) in order for the information to be included in the study.  If time allows in future 
studies, it will be beneficial for the investigators to contact the patients who would be possible 
participants via telephone or similar means to remind them to bring the completed VHI form 
with them to their stroboscopy appointment (if they would like to participate). This would need 
to occur should the study remain a prospective one.  It may also be advantageous to document 
the number of possible participants to whom the VHI is sent so that patient attendance or 
nonattendance to the initial stroboscopy appointment can be measured. 
 Due to the fast-paced nature of the clinic, many patients who could have been 
participants in the study were not included because of lack of time between patients to 
appropriately educate them about the study and obtain ethical informed consent.  This 
contributed to the low number of patient participants and, due to this small number, descriptive 
statistics were used rather than inferential statistics.  In future studies, if possible, it will be 
beneficial for the primary investigator to devote his/her attention to obtaining patient 
participation while other clinicians carry out the diagnostics.  
 Certainly, conducting a retrospective study would also allow more participants to be 
obtained.  This preliminary study identified numerous aspects of the current practice which may 
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be altered in order to ensure that all new voice patients are provided with the VHI and that it is 
collected as a part of the intake paperwork.  However, the clinic oftentimes treats 200-300 
patients per day, many of which are not voice patients.  It is likely that there will always be a 
group of patients who are not identified at intake and thus are not eligible for the study because 
they did not complete the VHI prior to stroboscopy.  
Summary and Conclusions 
 Data analysis demonstrated that the variables explored in the present study were not 
clinically or statistically significant in predicting patient adherence or compliance to 
recommendations to voice therapy.  These findings are consistent with those in a study by 
Hapner et al. (2007) who found that 65% of participants in their studied “dropped out” of voice 
therapy but that none of the factors they studied for predictor value (such as demographic 
information) were predictive of dropout.   
Recommendations for Future Research 
 The major contribution of this work compared to the literature was the addition of the 
adherence and attendance data.  Due to the prospective nature of this study, attendance was 
documented and adherence to therapy recommendations was rated by the clinicians.  It will be 
beneficial for future studies to record adherence and attendance as participants take part (or do 
not take part) in therapy.  In addition, temporal variables should be further assessed for their 
value in predicting completion of therapy. 
A follow-up interview with participants who were completely noncompliant to 
recommendations for voice therapy (those who received a rating of 4 for “termination reason”) 
could be conducted as was carried out by Portone et al. (2006).  The participants could be asked 
what they believe is the main reason for their nonadherence to recommendations for voice 
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therapy.  In addition, future studies may use more in-depth inferential statistics to report data, if 
enough data is collected to do so. 
As discussed previously, drop out from various types of therapy is typical and at times as 
high as 65%.  It is imperative that those in the field of these therapies, including SLP, continue to 
investigate reasons that could be contributing to too few patients receiving the care they need.  
Future research concerning this matter may aid in reducing unnecessary frustration for clinicians 
as well as unnecessary costs due to patient nonadherence. 
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APPENDIX A 
 
Voice Handicap Index (VHI) 
 
Name:               
 
Date:               
 
Instructions: 
These are statements that many people have used to describe their voices and the effects of their voices on their 
lives. Make a check in the box that indicates how frequently you have the same experience. 
 
 
 
 
 
 
Never 
 
Almost 
Never 
 
 
Sometimes 
 
Almost 
Always 
 
 
Always 
1. My voice makes it difficult for people to 
hear me. 
 
     
2. I run out of air when I talk. 
 
     
3. People have difficulty understanding me 
in a noisy room. 
 
     
4. The sound of my voice varies throughout 
the day. 
 
     
5. I use the phone less often than I would 
like. 
 
     
6. My family has difficulty hearing me when 
I call them throughout the house. 
 
     
7. I’m tense when talking with others 
because of my voice. 
 
     
8. I tend to avoid groups of people because 
of my voice. 
     
9. People seem irritated with my voice. 
 
     
10. People ask, “What’s wrong with your 
voice?” 
 
     
11. I speak with friends, neighbors, or 
relatives less often because of my voice. 
 
     
12. People ask me to repeat myself when 
speaking face to face. 
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13. My voice sounds creaky and dry. 
 
     
14. I feel as though I have to strain to 
produce voice. 
 
     
 
15. I find other people don’t understand my 
voice problem.  
 
 
 
 
 
 
 
 
 
 
 
16. My voice difficulties restrict my personal 
and social life. 
 
     
 
17. The clarity of my voice is unpredictable. 
 
 
 
 
 
 
 
 
 
 
 
18. I try to change my voice to sound 
different. 
 
     
19. I feel left out of conversations because of 
my voice. 
 
 
     
20. I use a great deal of effort to speak.  
 
     
21. My voice is worse in the evening. 
 
     
22. My voice problem causes me to lose 
income. 
 
     
23. My voice problem upsets me. 
 
     
24. I am less outgoing because of my voice 
problem.  
 
     
25. My voice makes me feel handicapped. 
 
     
26. My voice “gives out” on me in the 
middle of speaking. 
 
     
27. I feel annoyed when people ask me to 
repeat. 
 
     
28. I feel embarrassed when people ask me 
to repeat. 
 
     
29. My voice makes me feel incompetent. 
 
     
30. I’m ashamed of my voice problem.       







